Albrecht, T., Ruckdeschel, J., Riddle, D., Blanchard, C., Penner, L., Coovert, M., et al. (2003). Communication and consumer decision making about cancer clinical trials. Patient Education and Counseling, 50(1), 39-42.
2.
Chapple, A., Ziebland, S., & McPherson, A. (2004). Stigma, shame, and blame experienced by patients with lung cancer: Aualitative study. BMJ, 19(328), 1470.
3.
Gridelli, C., Aapro, M., Ardizzoni, A., Balducci, L., De Marinis, F., Kelly, K., et al. (2005). Treatment of advanced non-small-cell lung cancer in the elderly: Results of an international expert panel. Journal of Clinical Oncology, 23(13), 3125-3137.
4.
Jemal, A., Tiwan, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., et al. (2004). Cancer statistics, 2004. CA: A Cancer Journal for Clinicians, 54, 8-29.
5.
National Cancer Institute. (1999). Clinical trials: A blueprint for the future (Publ. No. T348). Retrieved from http://cancertrials.nci.nih.gov/researchers/restructuring
6.
Non-Small Cell Lung Cancer Collaborative Group. (1995). Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ, 311, 899-909.
7.
Quinn, G., Bepler, G., Bell, M., Carroway, V., Powell-Stafford, V., Schmizu, C., et al. (2005, July). Patient’s perceptions of thoracic clinical trials: Methods to improve accrual. Paper presented at the 11th World Conference on Lung Cancer, Barcelona, Spain.
8.
Sorensen, J. B., Rossel, P., & Holm, S. (2004). Patient-physician communication concerning participation in cancer chemotherapy trials. British Journal of Cancer, 90(2), 328-332.
